4,760
Net income (loss) $(14,830) $3,253 $(4,194)
US ONCOLOGY HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
(in thousands)
Year Ended
December 31,
2007 2006
Product revenue $1,970,106 $1,822,141
Service revenue 1,030,672 989,242
Total revenue 3,000,778 2,811,383
Cost of products 1,925,547 1,753,638
Cost of services:
Operating compensation and benefits 479,177 458,006
Other operating costs 293,677 274,665
Depreciation and amortization 73,159 69,351
Total cost of services 846,013 802,022
Total cost of products and services 2,771,560 2,555,660
General and administrative expenses 84,423 77,180
Impairment and restructuring charges 15,126 -
Depreciation and amortization 16,172 13,983
2,887,281 2,646,823
Income from operations 113,497 164,560
Other income (expense):
Interest expense, net (137,496) (117,088)
Minority interests (3,619) (2,388)
Loss on extinguishment of debt (12,917) -
Other income (expense) (11,885) -
Income
'/>"/>
SOURCE US Oncology Holdings, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 Related biology technology :1.
Six UK Hospitals Join Together in Using Varian Medical Oncology Information Network2.
Genstruct CEO, Dr. Keith Elliston, Invited to Speak at Oncology Clinical Trial Summit3.
Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)4.
Ranbaxy to Consolidate Position in Biopharmaceuticals and Speciality Injectables Including Oncology5.
Pharsight Invited to Present on Oncology Modeling and Simulation at Quantitative Pharmacology Symposium in China6.
PRA International to Present Audioconference on Oncology Research - Nov. 87.
IMPAC Medical Systems to Offer Revenue Cycle Inc.s Array of Oncology Products and Services to Customers8.
AG Mednet to Provide Image Network for Southwest Oncology Group9.
Quest PharmaTech to Receive $3,000,000 to Develop Oncology Products Based on its SonoLight Technology10.
Center for Molecular Medicine Selected to Provide DNA Analysis for Childrens Oncology Group Leukemia Study11.
Oncology Metrics and Cureline Announce Joint Marketing Agreement